Literature DB >> 17489577

Neuropathic pain: molecular complexity underlies continuing unmet medical need.

Jeffrey D Kennedy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17489577     DOI： 10.1021/jm061023c

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  12 in total

1.  Design and assessment of a potent sodium channel blocking derivative of mexiletine for minimizing experimental neuropathic pain in several rat models.

Authors:  Robert M Weston; Kamani R Subasinghe; Vasiliki Staikopoulos; Bevyn Jarrott
Journal:  Neurochem Res       Date:  2009-06-06       Impact factor: 3.996

Review 2.  Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics?

Authors:  Andreas Straube; Bernhard Aicher; Bernd L Fiebich; Gunther Haag
Journal:  BMC Neurol       Date:  2011-03-31       Impact factor: 2.474

3.  Swim therapy reduces mechanical allodynia and thermal hyperalgesia induced by chronic constriction nerve injury in rats.

Authors:  Jun Shen; Lyle E Fox; Jianguo Cheng
Journal:  Pain Med       Date:  2013-02-25       Impact factor: 3.750

4.  Differential effects of peripheral versus central coadministration of QX-314 and capsaicin on neuropathic pain in rats.

Authors:  Jun Shen; Lyle E Fox; Jianguo Cheng
Journal:  Anesthesiology       Date:  2012-08       Impact factor: 7.892

5.  The amide linker in nonpeptide neurotensin receptor ligands plays a key role in calcium signaling at the neurotensin receptor type 2.

Authors:  James B Thomas; Angela M Giddings; Srinivas Olepu; Robert W Wiethe; Keith R Warner; Philippe Sarret; Jean-Michel Longpre; Scott P Runyon; Brian P Gilmour
Journal:  Bioorg Med Chem Lett       Date:  2015-04-03       Impact factor: 2.823

6.  A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain.

Authors:  R D Andó; B Méhész; K Gyires; P Illes; B Sperlágh
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

7.  Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

Authors:  Michel Demeule; Nicolas Beaudet; Anthony Régina; Élie Besserer-Offroy; Alexandre Murza; Pascal Tétreault; Karine Belleville; Christian Ché; Alain Larocque; Carine Thiot; Richard Béliveau; Jean-Michel Longpré; Éric Marsault; Richard Leduc; Jean E Lachowicz; Steven L Gonias; Jean-Paul Castaigne; Philippe Sarret
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

Review 8.  Neuropathic pain after brachial plexus avulsion--central and peripheral mechanisms.

Authors:  Manoel Jacobsen Teixeira; Matheus Gomes da S da Paz; Mauro Tupiniquim Bina; Scheila Nogueira Santos; Irina Raicher; Ricardo Galhardoni; Diego Toledo Fernandes; Lin T Yeng; Abrahão F Baptista; Daniel Ciampi de Andrade
Journal:  BMC Neurol       Date:  2015-05-04       Impact factor: 2.474

9.  ω-Conotoxin GVIA mimetics that bind and inhibit neuronal Ca(v)2.2 ion channels.

Authors:  Charlotte Elisabet Tranberg; Aijun Yang; Irina Vetter; Jeffrey R McArthur; Jonathan B Baell; Richard J Lewis; Kellie L Tuck; Peter J Duggan
Journal:  Mar Drugs       Date:  2012-10-22       Impact factor: 6.085

10.  A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain.

Authors:  Cristina Nativi; Roberta Gualdani; Elisa Dragoni; Lorenzo Di Cesare Mannelli; Silvia Sostegni; Martina Norcini; Gabriele Gabrielli; Giancarlo la Marca; Barbara Richichi; Oscar Francesconi; Maria Rosa Moncelli; Carla Ghelardini; Stefano Roelens
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.